Only 200,000 of 250 million obese on GLP 1, Says Novo Nordisk as semaglutide Patent expires
As semaglutide went off-patent in India on March 20, innovator drugmaker Novo Nordisk said the market remains largely…
Generic medicine makers prepare to launch affordable options after Novo’s patent for Ozempic, Wegovy expires
Indian firms such as Ajanta Pharma, Dr Reddy’s Laboratories, Lupin, Mankind Pharma and Sun Pharmaceuticals are poised to…